Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck von Crombet Ramos, Tania, Mestre Fernández, Braulio, Mazorra Herrera, Zaima, Iznaga Escobar, Normando E

Volltext

Use of the Humanized Anti-Epidermal Growth Factor Receptor Monoclonal Antibody h-R3 in Combination With Radiotherapy in the Treatment of Locally Advanced Head and Neck Cancer Patie... von CROMBET, Tania, OSORIO, Marta, FERNANDEZ, Eduardo, ALVAREZ, Daniel, TORRES, Olga, RAMOS, Mayra, LEONARD, Idrissa, PEREZ, Rolando, LAGE, Agustin, CRUZ, Teresa, ROCA, Carlos, DEL CASTILLO, Ramon, MON, Rosa, IZNAGA-ESCOBAR, Normando, FIGUEREDO, René, KOROPATNICK, James, RENGINFO, Enrique

Volltext

A Potencial Theranostic Agent for EGF-R Expression Tumors: 177Lu- DOTA-Nimotuzumab von Victoria Calzada, Xiuli Zhang, Marcelo Fernandez, Arlhee Diaz-Miqueli, Normando Iznaga-Escobar, Susan L. Deutscher, Henia Balter, Thomas P. Quinn, Pablo Cabral

Volltext

Radiolabeling and biological evaluation of DOTA-Ph-Al derivative conjugated to anti-EGFR antibody ior egf/r3 for targeted tumor imaging and therapy von Panwar, Puja, Iznaga-Escobar, Normando, Mishra, Pushpa, Shrivastava, Vibha, Sharma, Rakesh Kumar, Chandra, Ramesh, Mishra, Anil Kumar

Volltext

Eficiencia del nimotuzumab en la atención a pacientes con cáncer de cabeza y cuello en Cuba von Pérez Ruiz, Leslie, Collazo Herrera, Manuel Miguel, Iznaga Escobar, Normando, García Fariñas, Anai, Ulises Garay, Osvaldo

Volltext

Diagnostic efficacy and safety of 99mTc-Labeled monoclonal antibody ior c5 in patients with colorectal and anal carcinomas: Final report clinical trial phase I/II von Ramos-Suzarte, Mayra, Perera Pintado, Alejandro, Mesa, Nelson Rodríguez, Oliva, Juan P., Iznaga-Escobar, Normando, Aroche, Leonel T., Pimentel, Gilmara, González, Joaquín, Cordero, Maria, Rodríguez, Obaya T., Crombet, Ramos T., Perez, R.

Volltext

Importancia de la farmacoeconomía en los ensayos clínicos con productos biotecnológicos von Pérez Ruiz, Leslie, Collazo Herrera, Manuel, Iznaga-Escobar, Normando

Volltext

Technetium-99m direct radiolabeling of monoclonal antibody ior egf/r3 von Morales, Alejo A.Morales, Crespo, Francisco Zayas, Gandolff, Gilda Núñez, Escobar, Normando Iznaga, Pérez, Niuvis Pérez, Hernández, Juan C.Izquierdo

Volltext

Direct radiolabeling of monoclonal antibodies with rhenium-188 for radioimmunotherapy of solid tumors — a review of radiolabeling characteristics, quality control and in vitro stab... von Iznaga-Escobar, Normando

Volltext

Preclinical studies predicting low clinical toxicity of the anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) nimotuzumab von Casacó, Angel, Ledón, Nuris, Iznaga-Escobar, Normando, Arteaga, Maria Elena, Crombet, Tania

Volltext

Clinical experience with nimotuzumab in cuban pediatric patients with brain tumors, 2005 to 2007 von Saurez, Giselle, Cabanas, Ricardo, Zaldívar, Melba, Garnier, Tania, Iglesias, Bárbara, Piedra, Patricia, Castillo, Martha Ríos, Longchong, Martha, Iznaga, Normando, Lage, Agustín

Volltext

Importancia de la farmacoeconomía en los ensayos clínicos con productos biotecnológicos von Pérez Ruiz, Leslie, Collazo Herrera, Manuel, Iznaga-Escobar, Normando

Volltext

Diagnostic efficacy and safety of 99m Tc-Labeled monoclonal antibody ior c5 in patients with colorectal and anal carcinomas: Final report clinical trial phase I/II von Ramos-Suzarte, Mayra, Perera Pintado, Alejandro, Mesa, Nelson Rodríguez, Oliva, Juan P., Iznaga-Escobar, Normando, Aroche, Leonel T., Pimentel, Gilmara, González, Joaquín, Cordero, Maria, Rodríguez, Obaya T., Crombet, Ramos T., Perez, R.

Volltext

188Re-Direct Labeling of Monoclonal Antibodies for Radioimmunotherapy of Solid Tumors: Biodistribution, Normal Organ Dosimetry, and Toxicology von Iznaga-Escobar, Normando

Volltext

Treatment of patients diagnosed with pancreatic ductal adenocarcinoma using monoclonal antibodies against the epidermal growth factor receptor (egfr) von Kerkhoff, Andrea, Hofheinz, Ralf, Overkamp, Friedrich, Ilyas, Rikrik, Rohrberg, Robert, Reuter, Dirk, Siveke, Jens, Goker, Erdem, Dommach, Markus, Schultheis, Beate, Yalcin, Suayib, Ebert, Matthias, Strumberg, Dirk, De Dosso, Sara, Kneba, Michael, Steinmetz, Tilman, Schmidt, Wolfgang, Iznaga Escobar, Normando, Behringer, Dirk, Schlegel, Frank, Bach, Ferdinand

Volltext bestellen

Local and systemic toxicity of h-R3, an anti-epidermal growth factor receptor monoclonal antibody, labeled with 188osmiun after the intracerebral administration in rats von Gonzalez Navarro, Barbara, Casacó Parada, Angel, Alvarez, Pio, Leon, Avelina, Santana, Edilis, Bada, Ana, Figueredo, Rene, Iznaga-Escobar, Normando, Perez, Rolando

Volltext

Local and systemic toxicity of h-R3, an anti-epidermal growth factor receptor monoclonal antibody, labeled with 188-osmiun after the intracerebral administration in rats von GONZALEZ NAVARRO, Barbara, CASACO PARADA, Angel, ALVAREZ, Pio, LEON, Avelina, SANTANA, Edilis, BADA, Ana, FIGUEREDO, Rene, IZNAGA-ESCOBAR, Normando, PEREZ, Rolando

Volltext

Factors affecting pharmacokinetics of monoclonal antibodies: A review article von IZNAGA-ESCOBAR, N, MISHRA, A. K, PEREZ-RODRIGUEZ, R

Volltext

Phase I/II clinical trial of the humanized anti-EGF-r monoclonal antibody h-R3 labelled with 99mTc in patients with tumour of epithelial origin von Torres, Leonel A, Perera, Alejandro, Batista, Juan F, Hernández, Abel, Crombet, Tania, Ramos, Mayra, Neninger, Elia, Pérez, Marilyn, Sánchez, Elvia L, Romero, Susana, Aguilar, Vicente, Coca, Marco A, Iznaga-Escobar, Normando

Volltext

Micromethod for quantification of SH groups generated after reduction of monoclonal antibodies von Escobar, Normando Iznaga, Morales, Alejo, Núñez, Gilda

Volltext